http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0161144-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4acae202b6a15394281949545e70d2f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-38
filingDate 1985-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1a05e11b282cb412f755ac00536774
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee70db1d5557ced78299439cc0b4695a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_143c4962e761529b7a7a2db91c9edbb9
publicationDate 1985-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0161144-A1
titleOfInvention Pharmaceutical composition for oral administration containing, on the one hand, as active principle the 9-alpha,11-beta dichloro-16-alpha methyl 21-oxycarbonyldicyclohexylmethyloxy pregna-1,4-diene 3,20-dione and, on the other hand, an inert pharmaceutical excipient which is able to permit the activity of the product in the rectum or in the colon and the utilization of the active principle in the preparation of such a pharmaceutical composition
abstract The subject of the present invention is a pharmaceutical composition containing, as active ingredient, 9α, 11 β-dichloro 16α-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione and an inert pharmaceutical excipient, able to allow the action of the product in the rectum or the colon. This composition is in particular in a form intended for the oral or rectal route.
priorityDate 1984-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2066070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2462443-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70401073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11245343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70401071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129547292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70401037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236264897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70491983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236244703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70491982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236244701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57137155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235872594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235872591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235872456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129026548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136002323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70500491

Total number of triples: 46.